Vascular access for daunorubicin during childhood acute lymphoblastic leukaemia induction treatment: A UKCCSG supportive care group and MRC childhood leukaemia working party survey

European Journal of Oncology Nursing

Volumn 12, Issue 5, 2008, Pages 476-478

  Selwood, Karen ^a   Pizer, Barry ^a   Gibson, Brenda ^b   Skinner, Roderick ^c  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

ALL; Children; Daunorubicin; Extravasation; Venous access; Venous thromboembolism

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; DAUNORUBICIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CATHETERIZATION; CENTRAL VENOUS CATHETERIZATION; CHILD; CLINICAL PRACTICE; CONTRAST MEDIUM EXTRAVASATION; EPIDEMIOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NURSING; PATIENT SELECTION; PRACTICE GUIDELINE; QUESTIONNAIRE; REMISSION; STATISTICS; THROMBOEMBOLISM; TIME; UNITED KINGDOM;

ANTIBIOTICS, ANTINEOPLASTIC; CATHETERIZATION, CENTRAL VENOUS; CATHETERIZATION, PERIPHERAL; CHILD; DAUNORUBICIN; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GREAT BRITAIN; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; INFUSIONS, INTRAVENOUS; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; QUESTIONNAIRES; REMISSION INDUCTION; THROMBOEMBOLISM; TIME FACTORS;

EID: 56949097569     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2008.08.002     Document Type: Article

References (17)

1. Athale U.H., and Chan A.K.C. Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia. Thrombosis research 111 3 (2003) 125-131
2. Athale U.H., and Chan A.K.C. Thrombosis in children with acute lymphoblastic leukemia: Part II. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of the disease and therapy. Thrombosis research 111 4-5 (2003) 199-212
3. Athale U.H., and Chan A.K.C. Thrombosis in children with acute lymphoblastic leukemia: Part III. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of host environment. Thrombosis research 111 6 (2003) 321-327
4. Athale U.H., Siciliano S.A., Crowther M., Barr R.D., and Chan A.K.C. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber cancer institute protocols: effect of age and risk stratification of disease. British Journal of Haematology 129 6 (2005) 803-810
5. Cheater F., and Closs S. The effectiveness of methods of dissemination and implementation of clinical guidelines for nursing practice: a selective review. Clinical Effectiveness in Nursing 1 1 (1997) 4-15
6. Cortelezzi A., Moia M., Falanga A., Pogliani E.M., Agnelli G., Bonizzoni E., Gussoni G., Barbui T., and Mannucci P.M. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. British Journal of Haematology 129 6 (2005) 811-817
7. Dorr R.T., Dordal M.S., Koenig L.M., Taylor C.W., and McCloskey T.M. High levels doxorubicin in the tissues of a patient experiencing extravasation during a 4-day infusion. Cancer 64 2 (1999) 2462-2464
8. Ener, R.A., Meglathery, S.B., Styler, M., 2004. Extravasation of systemic hemato-oncological therapies. Annals of Oncology 15(6), 858-862.
9. Grol, R., Dalhuijsen, J., Thomas, S., Veld, C., Rutten, G., Mokkink, H., 1998. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. British Medical Journal 317(7162), 858-861.
10. Hadaway L.C. Preventing and managing peripheral extravasation. Nursing 34 5 (2004) 66-67
11. Heitmann C., Durmas C., and Ingianni G. Surgical management after doxorubicin and epirubicin extravasation. Journal of Hand Surgery 23B (1998) 666-668
12. Khorana A.A., Francis C.W., Culakova E., Fisher R.I., Kuderer N.M., and Lyman G.H. Thromboembolism in hospitalized neutropenic cancer patients. Journal of Clinical Oncology 24 3 (2006) 484-490
13. Lee A.Y.Y., and Levine M.N. Venous thromboembolism and cancer: risks and outcomes. Circulation 107 23 (2003) 117-121
14. Mitchell L.G., Andrew M., Hanna K., Abshire T., Halton J., Anderson R., Cherrick I., Desai S., Mahoney D., McCuster P., Wu J., Dahl G., Chait P., de-Veber G., Lee K.J., Mikulis D., Ginsberg J., and Way C. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with l-asparaginase: results of the prophylactic antithrombin replacement in kids with acute lymphoblastic leukemia treated with asparaginase (PARKAA) study. Cancer 97 2 (2003) 508-516
15. Nowak-Göttl U., Wermes C., Junker R., Koch H.G., Schobess R., Fleischhack G., Schwabe D., and Ehrenforth S. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 93 5 (1999) 1595-1599
16. In: Polovich M., White J., and Kelleher L. (Eds). Chemotherapy and biotherapy guidelines and recommendations for practice. second ed. (2005), Oncology Nursing Society, Pittsburgh, Philadelphia
17. Sauerland C., Engelking C., Wickham R., and Corbi D. Vesicant extravasation part 1: mechanisms, pathogenesis, and nursing care to reduce risk. Oncology Nurses Forum 33 6 (2006) 1134-1141